We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare's (THC) Q1 Earnings: Is a Beat in Store?
Read MoreHide Full Article
Tenet Healthcare Corporation (THC - Free Report) will report first-quarter 2018 results on Apr 30 after market close.
Tenet Healthcare’s first-quarter results are likely to reflect the industry-wide softness in volumes. Factors such as payor initiatives to move volumes away from hospitals, rising deductibles and prevalence of high deductible health plans, increased proportion of hospital care to be paid by consumers, are driving away volumes and the same is likely to be seen in the to-be-reported quarter. These might in turn result in lower admissions inducing a decline in patient revenues.
However, an unusual flu season in the first quarter must have led to a surge in patient admissions as more patients seek treatment.
The Zacks Consensus Estimate for first-quarter inpatient revenues and outpatient revenues are pegged at $2.5 billion and $1.4 billion, reflecting 5.2% and 7.6% decline, respectively, over the year-ago quarter.
The consensus mark for - adjusted patient admissions in the quarter to be reported is pegged at 0.3 million, down 5.5% year over year.
Other Factors
Tenet Healthcare’s Ambulatory segment has been performing well over the past many quarters. The Zacks Consensus Estimate for this segment’s revenues stands at $486 million for the first quarter, reflecting 7% rise year over year. We expect the same to further benefit from this solid segmental performance.
The company’s cost management program primarily comprised headcount reductions and the renegotiation of contracts with suppliers and vendors. Its enterprise-wide cost-reduction initiatives are likely to decrease expenses and favor margins.
Further, the company’s share buybacks during the first quarter are expected to aid its bottom line.
Why a Likely Positive Surprise?
Our proven model shows that Tenet Healthcare has the right combination of the two key ingredients to beat estimates this quarter.
Zacks ESP: Tenet Healthcare has an Earnings ESPof +121.43%. The positive ESP indicates a likely earnings surprise. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Tenet Healthcare Corporation Price and EPS Surprise
Zacks Rank: Tenet Healthcare carries a Zacks Rank #3 (Hold). Notably, stocks with a favorable Zacks Rank #1 (Strong Buy), 2 or 3 (Hold) have significantly higher chances of an earnings beat.
Conversely, the Sell-rated stocks (#4 or 5) should never be considered going into an earnings announcement, especially when the company is seeing negative estimate revisions.
Other Stocks to Consider
Here are some other stocks worth considering from the medical sector that you may want to consider as these too have the right combination of elements to come up with an earnings beat this time around:
Aetna, Inc. has an Earnings ESP of +0.43% and a Zacks Rank of 3. The company is set to report first-quarter earnings on May 1.
Wellcare Health Plans, Inc. has an Earnings ESP of +3.89% and is a Zacks #2 Ranked player. The company is expected to report first-quarter earnings on May 1.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Tenet Healthcare's (THC) Q1 Earnings: Is a Beat in Store?
Tenet Healthcare Corporation (THC - Free Report) will report first-quarter 2018 results on Apr 30 after market close.
Tenet Healthcare’s first-quarter results are likely to reflect the industry-wide softness in volumes. Factors such as payor initiatives to move volumes away from hospitals, rising deductibles and prevalence of high deductible health plans, increased proportion of hospital care to be paid by consumers, are driving away volumes and the same is likely to be seen in the to-be-reported quarter. These might in turn result in lower admissions inducing a decline in patient revenues.
However, an unusual flu season in the first quarter must have led to a surge in patient admissions as more patients seek treatment.
The Zacks Consensus Estimate for first-quarter inpatient revenues and outpatient revenues are pegged at $2.5 billion and $1.4 billion, reflecting 5.2% and 7.6% decline, respectively, over the year-ago quarter.
The consensus mark for - adjusted patient admissions in the quarter to be reported is pegged at 0.3 million, down 5.5% year over year.
Other Factors
Tenet Healthcare’s Ambulatory segment has been performing well over the past many quarters. The Zacks Consensus Estimate for this segment’s revenues stands at $486 million for the first quarter, reflecting 7% rise year over year. We expect the same to further benefit from this solid segmental performance.
The company’s cost management program primarily comprised headcount reductions and the renegotiation of contracts with suppliers and vendors. Its enterprise-wide cost-reduction initiatives are likely to decrease expenses and favor margins.
Further, the company’s share buybacks during the first quarter are expected to aid its bottom line.
Why a Likely Positive Surprise?
Our proven model shows that Tenet Healthcare has the right combination of the two key ingredients to beat estimates this quarter.
Zacks ESP: Tenet Healthcare has an Earnings ESPof +121.43%. The positive ESP indicates a likely earnings surprise. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Tenet Healthcare Corporation Price and EPS Surprise
Tenet Healthcare Corporation Price and EPS Surprise | Tenet Healthcare Corporation Quote
Zacks Rank: Tenet Healthcare carries a Zacks Rank #3 (Hold). Notably, stocks with a favorable Zacks Rank #1 (Strong Buy), 2 or 3 (Hold) have significantly higher chances of an earnings beat.
Conversely, the Sell-rated stocks (#4 or 5) should never be considered going into an earnings announcement, especially when the company is seeing negative estimate revisions.
Other Stocks to Consider
Here are some other stocks worth considering from the medical sector that you may want to consider as these too have the right combination of elements to come up with an earnings beat this time around:
Humana Inc. (HUM - Free Report) is scheduled to report first-quarter earnings on May 2. The company has an Earnings ESP of +0.20% and a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Aetna, Inc. has an Earnings ESP of +0.43% and a Zacks Rank of 3. The company is set to report first-quarter earnings on May 1.
Wellcare Health Plans, Inc. has an Earnings ESP of +3.89% and is a Zacks #2 Ranked player. The company is expected to report first-quarter earnings on May 1.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>